7 March 2012
An innovative drug has been approved to be used in the UK, in a development which is set to better assist people suffering from heart problems.
Ivabradine is aimed to help people who have chronic heart failure and has been licensed for British distribution following the results of a study concerning the drug.
More than 6,000 people suffering from chronic heart failure were trialled with the drug, results of which revealed that Ivabradine could help improve the quality of life of patients and also enhance the detection of heart failure symptoms.
This is because the innovative drug was found to slow the heart rate of a patient, thus increasing the effectiveness of pumping blood around a body.
Maureen Talbot, a senior cardiac nurse at the British Heart Foundation, added: "Knowing doctors have another option to offer those patients whose condition is particularly difficult to treat is really positive news."
She was keen to note though that people who already have medication which helps to control heart failure are "unlikely to have their medication changed".
A recent study by Lakeland Regional Medical Center suggested that women have different symptoms for heart problems than men do.
Posted by Edward Bartel
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.